Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 56: 1340-1346, 1984;
8750-7587/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morganroth, M. L.
Right arrow Articles by Voelkel, N. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morganroth, M. L.
Right arrow Articles by Voelkel, N. F.

Journal of Applied Physiology, Vol 56, Issue 5 1340-1346, Copyright © 1984 by American Physiological Society

ARTICLES

Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction

M. L. Morganroth, J. T. Reeves, R. C. Murphy and N. F. Voelkel

We hypothesized that leukotrienes are involved in hypoxic pulmonary vasoconstriction, since they are pulmonary vasoconstrictors and cells capable of producing leukotrienes are located in the lung near resistance vessels. We investigated in isolated perfused rat lungs whether three structurally unrelated blockers [diethylcarbamazine citrate (DEC), U-60257, and FPL 55712] of leukotriene synthesis or action block hypoxic pulmonary vasoconstriction. DEC blocked ongoing and subsequent hypoxic pressor responses while minimally affecting the angiotensin II pressor response. The inhibition of the hypoxic pressor response by DEC was not affected by cyclooxygenase or H1-receptor blockers. Potassium-induced vasoconstriction, which is dependent on calcium entry, was largely blocked by verapamil but not by DEC, suggesting that DEC was not acting primarily as a calcium-entry blocker. U-60257 blocked the hypoxic pressor response without inhibiting the pressor response to angiotensin II or potassium chloride. FPL 55712, a leukotriene end-organ blocker, in a dose which inhibited vasoconstriction caused by exogenous leukotriene C4, inhibited the pressor response to hypoxia but not to angiotensin II. We conclude that leukotriene inhibitors preferentially inhibit hypoxic pulmonary vasoconstriction in isolated perfused adult rat lungs.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Jones, J. L. Walker, Y. Song, N. Weiss, W. V. Cardoso, R. M. Tuder, J. Loscalzo, and Y.-Y. Zhang
Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1775 - H1784.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. S. Robinson, D. A. Rathjen, N. A. Trout, C. J. Easton, and A. Ferrante
Inhibition of Neutrophil Leukotriene B4 Production by a Novel Synthetic N-3 Polyunsaturated Fatty Acid Analogue, {beta}-Oxa 21:3n-3
J. Immunol., November 1, 2003; 171(9): 4773 - 4779.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
M. V. Cutaia and S. Rounds
Analytic Reviews : Hypoxic Pulmonary Vasoconstriction: Physiology and Pathophysiology
J Intensive Care Med, September 1, 1989; 4(5): 186 - 191.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online